Mauro Viganò

14PUBLICATIONS
76CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCardiology (incl. cardiovascular diseases)Predictive and prognostic markersPolitical economy and social changeMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 21, 2026
Applicability of Non-Invasive Eligibility Criteria for MASH Pharmacotherapy: A Multicentre Cohort Study.

|Apr 21, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European Study.

|Feb 27, 2026
RETREAT Score Accurately Predicts the Long-Term Risk of HCC Recurrence After Liver Transplantation: A Single-Center Real-Life Validation.

Flavia Neri, Mauro Viganò, Stefania Camagni

|Sep 04, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database.

Alessandro Loglio, Ivan Gardini, Massimiliano Conforti

|Feb 26, 2025
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study.

Luca Rinaldi, Mauro Viganò, Alessia Ciancio

|Jan 11, 2025
Hepatotoxicity in Cancer Immunotherapy: Diagnosis, Management, and Future Perspectives.

Alberto Savino, Alberto Rossi, Stefano Fagiuoli

Pageof 3

Frequent Collaborators

7 joint publications

Alessandro Loglio

6 joint publications

Stefano Fagiuoli

3 joint publications

Pietro Invernizzi

3 joint publications

Pietro Lampertico